共 241 条
[11]
Doudna Cate J(2021)RPL19 is a prognostic biomarker and promotes tumor progression in hepatocellular carcinoma Front Cell Dev Biol 9 D956-404
[12]
Ebright R(2016)Comprehensive analyses of tumor immunity: implications for cancer immunotherapy Genome Biol 17 401-1474
[13]
Lee S(2017)TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells Can Res 77 1467-203
[14]
Wittner B(2017)UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses Neoplasia (New York, NY) 19 187-235
[15]
Niederhoffer K(2021)Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer Comput Struct Biotechnol J 19 229-4956
[16]
Nicholson B(1987)ras p21 expression in the progression of breast cancer Hum Pathol 18 4947-533
[17]
Bardia A(2018)LinkedOmics: analyzing multi-omics data within and across 32 cancer types Nucleic Acids Res 46 529-559
[18]
Yan W(2012)The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data Cancer Discov 2 551-1790
[19]
Li S(2016)The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma Ann Oncol 27 1773-165
[20]
Gao H(2008)Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries Annu Rev Public Health 29 139-1118